News Daily News CV Screening, Care at UK Football Club Made Inroads Against HF Caitlin E. Cox March 07, 2025
Presentation THT 2024 Beyond BeAT-HF: Real-world Experience with Barostim Presenter: gurusher panjrath March 05, 2024
Presentation THT 2024 Long-term Results of the BeAT-HF Clinical Study Presenter: JoAnn Lindenfeld March 05, 2024
Presentation THT Abstracts 2024 Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: JoAnn Lindenfeld March 04, 2024
Presentation THT Abstracts 2024 Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: William Abraham March 04, 2024
Presentation THT 2024 Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: William T. Abraham March 04, 2024
Presentation THT 2024 Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: JoAnn Lindenfeld March 04, 2024
Presentation THT 2023 Incorporating Barostim into a Heart Failure Program Presenter: Patrick McCann March 21, 2023
Presentation THT 2023 Baroreflex Activation Therapy Mechanism of Action & BeAT-HF Study Design Presenter: JoAnn Lindenfeld March 21, 2023
Presentation THT 2023 Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes Presenter: Michael Zile March 21, 2023
News Features Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses Shelley Wood December 23, 2019
News Daily News FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure Todd Neale August 19, 2019
News Conference News HRS 2019 BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients Todd Neale May 15, 2019
News Industry News CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure June 06, 2016
News Industry News CVRx® Announces Expedited Access Pathway Designation By FDA for Barostim Therapy® for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients November 18, 2015